Preclinical safety and antitumor efficacy of insulin combined with irradiation

Radiotherapy and Oncology

Volumn 81, Issue 1, 2006, Pages 112-117

  Jordan, Bénédicte F ^a,b   Beghein, Nelson ^a,b   Crokart, Nathalie ^a   Baudelet, Christine ^a,b   Grégoire, Vincent ^c   Gallez, Bernard ^a,b  

^a Laboratory of Biomedical Magnetic Resonance   (Belgium)

^b Laboratory of Medicinal Chemistry and Radiopharmacy   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Insulin; Irradiation; Oxygenation; Preclinical; Tumor

Indexed keywords

INSULIN; NEUTRAL INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CONTRACTURE; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; ELECTRON SPIN RESONANCE; FIBROSARCOMA; GLUCOSE INFUSION; HYPOGLYCEMIA; IN VIVO STUDY; INTESTINE CRYPT; IRRADIATION; MOUSE; NONHUMAN; OUTPATIENT DEPARTMENT; OXIMETRY; OXYGENATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSENSITIZATION; TISSUE REGENERATION; TUMOR GROWTH;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FIBROSARCOMA; INSULIN; MICE; OXYGEN; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS;

EID: 33749608983     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.08.023     Document Type: Article

References (29)

1. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49 (1989) 6449-6465
2. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
3. Evans S.M., and Koch C.J. Prognostic significance of tumor oxygenation in humans. Cancer Lett 195 (2003) 1-16
4. Menon C., and Fraker D.L. Tumor oxygenation status as a prognostic marker. Cancer Lett 22 (2005) 225-235
5. Gallez B., Baudelet C., and Jordan B.F. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. NMR Biomed 17 (2004) 240-262
6. Kaanders J.H., Bussink J., and van der Kogel A.J. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 14 (2004) 233-240
7. Stubbs M., Robinson S.P., Hui C., et al. The importance of tumor metabolism in cancer prognosis and therapy; pre-clinical studies on rodent tumors with agents that improve tumor oxygenation. Adv Enzyme Regul 42 (2002) 131-141
8. Song C.W., Park H., and Griffin R.J. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 5 (2001) 515-528
9. Wouters B.G., Weppler S.A., Koritzinsky M., et al. Hypoxia as a target for combined modality treatments. Eur J Cancer 38 (2002) 240-257
10. Kleinberg L., Grossman S.A., Carson K., et al. Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study. J Clin Oncol 20 (2002) 3149-3155
11. Bussink J., Kaanders J.H., and Van der Kogel A.J. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide. Acta Oncol 38 (1999) 875-882
12. Gallez B., Jordan B.F., Baudelet C., and Misson P.D. Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry. Magn Reson Med 42 (1999) 627-630
13. Pogue B.W., O'Hara J.A., Demidenko E., et al. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res 63 (2003) 1025-1033
14. Hou H., Khan N., O'Hara J.A., et al. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: in vivo EPR oximetry study. Int J Radiat Oncol Biol Phys 61 (2005) 1503-1509
15. Secomb T.W., Hsu R., Ong E.T., Gross J.F., and Dewhirst M.W. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol 34 (1995) 313-316
16. Thews O., Kelleher D.K., Hummel M., and Vaupel P. Can tumor oxygenation be improved by reducing cellular oxygen consumption. Adv Exp Med Biol 471 (1999) 525-532
17. Jordan B.F., Gregoire V., Demeure R.J., et al. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res 62 (2002) 3555-3561
18. Jordan B.F., Sonveaux P., Feron O., et al. Nitric oxide as a radiosensitizer: evidence for an intrinsic role in addition to its effect on oxygen delivery and consumption. Int J Cancer 109 (2004) 768-773
19. Clementi E., Brown G.C., Foxwell N., and Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA 96 (1999) 1559-1562
20. Withers H.R., and Elkind M.M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med 17 (1970) 261-267
21. Stone H.B. Leg contracture in mice: an assay of normal tissue response. Int J Radiat Oncol Biol Phys 10 (1984) 1053-1061
22. Brizel D.M., Dodge R.K., Clough R.W., and Dewhirst M.W. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53 (1999) 113-117
23. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
24. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
25. Denny W.A. The role of hypoxia-activated prodrugs in cancer therapy. Lancet Oncol 1 (2000) 25-29
26. Kaanders J.H., Bussink J., and Van der Kogel A.J. ARCON : a novel biology-based approach in radiotherapy. Lancet Oncol 3 (2002) 728-737
27. Biaglow J.E., Manevich Y., Leeper D., et al. MIBG inhibits respiration: potential for radio- and hyperthermic sensitization. Int J Radiat Oncol Biol Phys 42 (1998) 871-876
28. Crokart N., Radermacher K., Jordan B.F., et al. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Res 65 (2005) 7911-7916
29. Swartz H.M., Khan N., Buckey J., et al. Clinical applications of EPR: overview and perspectives. NMR Biomed 17 (2004) 335-351